疏肝健脾膏对躯体性亚健康人群疲乏及睡眠质量的影响

Effect of Shugan Jianpi Ointment on Fatigue and Sleep Quality of Somatic Sub-healthy People

目的探讨疏肝健脾膏对躯体性亚健康人群疲乏及睡眠质量的影响。方法于本院治未病中心选择2015年4月-2017年4月接受治疗的躯体性亚健康人群86例作为观察对象,将他们随机分成两组,对照组和治疗组分别为43人。对照组不采取任何治疗措施,治疗组给予疏肝健脾治疗,观察两组各项指标。对两组患者的一般临床资料、疲劳程度和睡眠质量等方面的数据进行统计分析。结果两组患者性别、文化水平、婚姻状况、家庭收入等一般资料无显著差异,不具统计学意义(P>0.05)。治疗后,对照组较重度和重度疲劳发生率增加;而治疗组较重和重度疲劳发生率明显减少,且两组间比较差异显著,有统计学意义(P<0.05);治疗组患者睡眠质量评分、入睡时间评分、睡眠效率、睡眠障碍评分、日间紊乱评分、PSQI总分等指标均优于对照组,与治疗前比较均明显降低,差异显著,各项均有统计学意义(P<0.05);治疗组总有效率(79.07%)较对照组(6.98%)显著提高,差异显著,具有统计学意义(P<0.05)。结论疏肝健脾膏能有效改善躯体性亚健康人群疲乏症状,提高睡眠质量,疗效确切,具有较高的临床推广价值。

Objective To investigate the effects of Shugan Jianpi ointment on fatigue and sleep quality of somatic subhealthy people. Methods Eighty-six cases of somatic sub-health who received treatment between April 2015 and April 2017 were randomly divided into two groups,with forty-three cases in each. The control group received no treatment,while the treatment group was treated with Shugan Jianpi ointment. Indicators of the two groups were observed. The general clinical data,fatigue and sleep quality of the two groups were analyzed statistically. Results There was no significant difference in gender,educational levels,marital status or family incomes between the two groups（ P〈0.05）.After treatment,the incidence of mild and severe fatigue increased in the control group,but significantly decreased in the treatment group（ P〈0.05）. The scores of sleep quality,sleep time,sleep efficiency,sleep disorder,daytime disorder and PSQI were better in the treatment group than in the control group,and were significantly lower after treatment. The difference was of statistical significance（ P〈0.05）.The total effective rate of the treatment group（ 79.07%） was significantly higher than that of the control group（ 6.98%）. The difference was statistically significant（ P〈0.05）. Conclusion Shugan Jianpi ointment can effectively improve the fatigue symptoms and sleep quality of somatic sub-healthy populations,with definite curative effect,and is worthy of clinical popularization.